D
Don Kirkman
Guest
It seems to me I heard somewhere that Sharon Hope wrote in article
<zeNgb.709841$uu5.116644@sccrnsc04>:
>What if you gave your child a pill while he went to school from K-12, and
>each year he advanced only half as much as his average classmates? Would
>you be pleased that he had achieved a "statistically significant
>improvement" by performing at the middle of 5th grade-equivalent as a
>graduating senior in the 12th grade? Would you be recommending that pill to
>your friends with children?
>Dr. Muldoon's research study, which was conducted for only 6 months, showed
>some horrifying results. Both the placebo and the statin groups underwent
>neuropsych testing before the treatment, and they were tested again after
>only 6 months.
>ONE HUNDRED PERCENT of the statin group had a measurable DECLINE in their
>own performance (they scored lower than before on a test they had just taken
>6 months ago) in Attention, Psychomotor Speed, and Mental Flexibility.
[...]
>This is not a 'trend' nor is it a 'small percentage' nor is it a simple
>majority, it is BINARY. ONE HUNDRED PERCENT of those who took statins,
>declined mentally in some areas and failed to thrive in other areas, after
>only 6 months!
This causes me to wonder about the protocols and design of Dr. Muldoon's
studies. One would expect that if 100% of statin users develop these
symptoms within six months clinical doctors might have noticed it in
their patients.
I've been on statins for five years, and I don't think I have any of
these neurotoxic effects. Of course if my mental flexibility,
attention, cognition, and memory have been damaged I might not be aware
of it.
>Looking at these numbers from my perspective, with a 55 year old husband,
>twice a CEO, who was on Lipitor for 4 years and is now totally disabled with
>muscle wasting, pain, cramping, polyneuropathy, transcient global amnesia,
>aphasia, having concentration problems and scoring BELOW THE 1 PERCENTILE IN
>SHORT-TERM MEMORY, it is obvious that the Muldoon results show a pattern of
>continuing degeneration, perhaps accelerating degeneration, but only the
>first 6 months of this progression was measured.
[...]
>Unless and until the FDA acknowledges the adverse mental and cognitive
>effects of statins, there will be no research into screening out statin
>patients who would be more likely to sustain such a loss. There will also
>be no research into the issues such as 1) is this permanent brain damage?
>and 2) is there any kind of treatment to restore some cognitive and memory
>function?
>"Jim Chinnis" <[email protected]> wrote in message
>news:[email protected]...
>> "Bill" <***@yy.zz> wrote in part:
>> I have found the same thing in reading through Sharon's cited articles.
>One
>> which had been described as finding that 100% of the statin treatment
>group
>> suffered cognitive decline actually found a statistically significant
>> improvement in memory in the treatment group, just as one example.
--
Don
[email protected]
<zeNgb.709841$uu5.116644@sccrnsc04>:
>What if you gave your child a pill while he went to school from K-12, and
>each year he advanced only half as much as his average classmates? Would
>you be pleased that he had achieved a "statistically significant
>improvement" by performing at the middle of 5th grade-equivalent as a
>graduating senior in the 12th grade? Would you be recommending that pill to
>your friends with children?
>Dr. Muldoon's research study, which was conducted for only 6 months, showed
>some horrifying results. Both the placebo and the statin groups underwent
>neuropsych testing before the treatment, and they were tested again after
>only 6 months.
>ONE HUNDRED PERCENT of the statin group had a measurable DECLINE in their
>own performance (they scored lower than before on a test they had just taken
>6 months ago) in Attention, Psychomotor Speed, and Mental Flexibility.
[...]
>This is not a 'trend' nor is it a 'small percentage' nor is it a simple
>majority, it is BINARY. ONE HUNDRED PERCENT of those who took statins,
>declined mentally in some areas and failed to thrive in other areas, after
>only 6 months!
This causes me to wonder about the protocols and design of Dr. Muldoon's
studies. One would expect that if 100% of statin users develop these
symptoms within six months clinical doctors might have noticed it in
their patients.
I've been on statins for five years, and I don't think I have any of
these neurotoxic effects. Of course if my mental flexibility,
attention, cognition, and memory have been damaged I might not be aware
of it.
>Looking at these numbers from my perspective, with a 55 year old husband,
>twice a CEO, who was on Lipitor for 4 years and is now totally disabled with
>muscle wasting, pain, cramping, polyneuropathy, transcient global amnesia,
>aphasia, having concentration problems and scoring BELOW THE 1 PERCENTILE IN
>SHORT-TERM MEMORY, it is obvious that the Muldoon results show a pattern of
>continuing degeneration, perhaps accelerating degeneration, but only the
>first 6 months of this progression was measured.
[...]
>Unless and until the FDA acknowledges the adverse mental and cognitive
>effects of statins, there will be no research into screening out statin
>patients who would be more likely to sustain such a loss. There will also
>be no research into the issues such as 1) is this permanent brain damage?
>and 2) is there any kind of treatment to restore some cognitive and memory
>function?
>"Jim Chinnis" <[email protected]> wrote in message
>news:[email protected]...
>> "Bill" <***@yy.zz> wrote in part:
>> I have found the same thing in reading through Sharon's cited articles.
>One
>> which had been described as finding that 100% of the statin treatment
>group
>> suffered cognitive decline actually found a statistically significant
>> improvement in memory in the treatment group, just as one example.
--
Don
[email protected]